Stéphane Bancel, Getty

As Covid-19 vac­cine was be­ing de­vel­oped, Mod­er­na shelled out more than $1M for top ex­ec­u­tives' se­cu­ri­ty

As Mod­er­na worked in over­drive to cre­ate the sec­ond Covid-19 vac­cine grant­ed emer­gency use au­tho­riza­tion by the FDA, it spent more than $1.1 mil­lion on …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.